<p>富兰克林资源公司在第二季度购买了 Omada Health, Inc.（NASDAQ:OMDA - 免费报告）的新股份，根据该公司最近向证券交易委员会提交的 13F 文件。该基金购买了 147,251 股公司的股票，价值约为 2,695,000 美元。富兰克林资源公司在最近一个季度末持有 Omada Health 约 0.57% 的股份。</p>
<p>其他几家机构投资者也最近调整了对该公司的持股。Geode Capital Management LLC 在第二季度购买了价值约 637,000 美元的 Omada Health 新头寸。德克萨斯州教师退休系统在第二季度购买了价值约 640,000 美元的 Omada Health 新头寸。Emerald Mutual Fund Advisers Trust 在第二季度购买了价值约 2,950,000 美元的 Omada Health 新股份。Jennison Associates LLC 在第二季度购买了价值约 4,580,000 美元的 Omada Health 新股份。最后，Emerald Advisers LLC 在第二季度购买了价值约 5,089,000 美元的 Omada Health 新股份。</p>
<h2>华尔街分析师预测增长</h2>
<p>几家研究公司对 OMDA 发表了评论。Needham &amp; Company LLC 将 Omada Health 的目标价格从 26.00 美元上调至 28.00 美元，并在 11 月 7 日的报告中给予该股票 “买入” 评级。巴克莱将 Omada Health 的目标价格从 28.00 美元上调至 29.00 美元，并在 11 月 7 日的研究报告中给予该股票 “增持” 评级。Evercore ISI 将 Omada Health 的目标价格从 27.00 美元上调至 28.00 美元，并在 11 月 7 日的研究报告中给予该公司 “跑赢大盘” 评级。Canaccord Genuity Group 将 Omada Health 的目标价格从 27.00 美元上调至 28.00 美元，并在 8 月 8 日的研究报告中给予该股票 “买入” 评级。最后，Baird R W 在 9 月 5 日的报告中将 Omada Health 的股票评级上调至 “持有”。八位分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价格为 26.33 美元。</p>
<p><strong>查看我们对 Omada Health 的最新股票分析</strong></p>
<h2>Omada Health 股价下跌 12.6%</h2>
<p>OMDA 周四开盘价为 16.13 美元。该公司的 50 日移动平均线为 22.24 美元。Omada Health, Inc.的 52 周低点为 14.14 美元，52 周高点为 28.40 美元。</p>
<h2>Omada Health 简介</h2>
<p>（免费报告）</p>
<p>Omada 的使命是改变趋势。我们的希望是，有一天，明天的流行病学家会注意到疾病曲线的变化，想知道发生了什么，并得出部分影响来自 Omada 的结论。作为这一使命的一部分，我们努力激励和帮助人们以自己的方式实现持久的健康改变。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票超过 Omada Health</li>
<li>股票中的死亡交叉是什么？</li>
<li>3 只有望受益于谷歌 AI 突破的股票</li>
<li>上海证券交易所综合指数是什么？</li>
<li>超越 NVIDIA：5 只将在 2026 年主导的半导体股票</li>
<li>股息之王宝洁在财报后疲软时值得买入</li>
<li>3 只你会希望在 2026 年前买入的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Omada Health 吗？</h2>
<p>在你考虑 Omada Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出顶级分析师正在悄悄向客户推荐的五只股票，建议现在买入，以便在更广泛的市场注意到之前……而 Omada Health 并不在名单上。</p>
<p>虽然 Omada Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得买入。</p>
<p>在这里查看这五只股票</p>

OMDA

富兰克林资源

<p>富兰克林资源公司在第二季度收购了 147,251 股 Omada Health 公司的股份，价值为 2,695,000 美元。分析师对 Omada Health 给予了 “适度买入” 的评级，目标价格范围在 26 美元到 29 美元之间。尽管如此，该股票目前交易下跌 12.6%，报 16.13 美元。在同一时期，其他几家机构投资者也购买了 Omada Health 的股份</p>

<p>Franklin Resources Inc. bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 147,251 shares of the company's stock, valued at approximately $2,695,000. Franklin Resources Inc. owned approximately 0.57% of Omada Health at the end of the most recent quarter.</p>
<div class="lb-trans"><p>富兰克林资源公司在第二季度购买了 Omada Health, Inc.（NASDAQ:OMDA - 免费报告）的新股份，根据该公司最近向证券交易委员会提交的 13F 文件。该基金购买了 147,251 股公司的股票，价值约为 2,695,000 美元。富兰克林资源公司在最近一个季度末持有 Omada Health 约 0.57% 的股份。</p>
</div><p>Several other institutional investors also recently modified their holdings of the business. Geode Capital Management LLC purchased a new position in Omada Health during the 2nd quarter valued at about $637,000. Teacher Retirement System of Texas purchased a new position in shares of Omada Health during the second quarter valued at approximately $640,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Omada Health in the 2nd quarter worth approximately $2,950,000. Jennison Associates LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $4,580,000. Finally, Emerald Advisers LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $5,089,000.</p>
<div class="lb-trans"><p>其他几家机构投资者也最近调整了对该公司的持股。Geode Capital Management LLC 在第二季度购买了价值约 637,000 美元的 Omada Health 新头寸。德克萨斯州教师退休系统在第二季度购买了价值约 640,000 美元的 Omada Health 新头寸。Emerald Mutual Fund Advisers Trust 在第二季度购买了价值约 2,950,000 美元的 Omada Health 新股份。Jennison Associates LLC 在第二季度购买了价值约 4,580,000 美元的 Omada Health 新股份。最后，Emerald Advisers LLC 在第二季度购买了价值约 5,089,000 美元的 Omada Health 新股份。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several research firms have commented on OMDA. Needham &amp; Company LLC boosted their target price on Omada Health from $26.00 to $28.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, November 7th. Barclays upped their price target on shares of Omada Health from $28.00 to $29.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, November 7th. Evercore ISI raised their price objective on shares of Omada Health from $27.00 to $28.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, November 7th. Canaccord Genuity Group upped their target price on shares of Omada Health from $27.00 to $28.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, August 8th. Finally, Baird R W upgraded shares of Omada Health to a &#34;hold&#34; rating in a report on Friday, September 5th. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $26.33.</p>
<div class="lb-trans"><p>几家研究公司对 OMDA 发表了评论。Needham &amp; Company LLC 将 Omada Health 的目标价格从 26.00 美元上调至 28.00 美元，并在 11 月 7 日的报告中给予该股票 “买入” 评级。巴克莱将 Omada Health 的目标价格从 28.00 美元上调至 29.00 美元，并在 11 月 7 日的研究报告中给予该股票 “增持” 评级。Evercore ISI 将 Omada Health 的目标价格从 27.00 美元上调至 28.00 美元，并在 11 月 7 日的研究报告中给予该公司 “跑赢大盘” 评级。Canaccord Genuity Group 将 Omada Health 的目标价格从 27.00 美元上调至 28.00 美元，并在 8 月 8 日的研究报告中给予该股票 “买入” 评级。最后，Baird R W 在 9 月 5 日的报告中将 Omada Health 的股票评级上调至 “持有”。八位分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价格为 26.33 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on Omada Health</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Omada Health 的最新股票分析</strong></p>
</div><h2>Omada Health Trading Down 12.6%</h2>
<div class="lb-trans"><h2>Omada Health 股价下跌 12.6%</h2>
</div><p>OMDA opened at $16.13 on Thursday. The company's 50-day moving average is $22.24. Omada Health, Inc. has a 52-week low of $14.14 and a 52-week high of $28.40.</p>
<div class="lb-trans"><p>OMDA 周四开盘价为 16.13 美元。该公司的 50 日移动平均线为 22.24 美元。Omada Health, Inc.的 52 周低点为 14.14 美元，52 周高点为 28.40 美元。</p>
</div><h2>Omada Health Profile</h2>
<div class="lb-trans"><h2>Omada Health 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.</p>
<div class="lb-trans"><p>Omada 的使命是改变趋势。我们的希望是，有一天，明天的流行病学家会注意到疾病曲线的变化，想知道发生了什么，并得出部分影响来自 Omada 的结论。作为这一使命的一部分，我们努力激励和帮助人们以自己的方式实现持久的健康改变。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>What is a Death Cross in Stocks?</li>
<li>3 Stocks Poised to Benefit From Google’s AI Breakthough</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026</li>
<li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness</li>
<li>3 Stocks You’ll Wish You Bought Before 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Omada Health</li>
<li>股票中的死亡交叉是什么？</li>
<li>3 只有望受益于谷歌 AI 突破的股票</li>
<li>上海证券交易所综合指数是什么？</li>
<li>超越 NVIDIA：5 只将在 2026 年主导的半导体股票</li>
<li>股息之王宝洁在财报后疲软时值得买入</li>
<li>3 只你会希望在 2026 年前买入的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=OMDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Omada Health 吗？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Omada Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出顶级分析师正在悄悄向客户推荐的五只股票，建议现在买入，以便在更广泛的市场注意到之前……而 Omada Health 并不在名单上。</p>
</div><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Omada Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得买入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

富兰克林资源公司对 Omada Health 公司进行了新的投资 $OMDA